Thursday, 9 August 2007

Avandia is still on the market, despite risks

Filed under: , ,

Most of us have heard of the risks associated with diabetes medication Avandia -- which include raising the risk of heart attack by 43% and raising the risk of dying from heart-related problems by 64%. But despite all this, Avandia is still on the market, and it's going to remain there, as the FDA has recommended that it continue to be sold, albeit with a stronger warning about it's potential to lead to heart problems and even death.

What's frightening is that type-2 diabetes patients often already have heart problems, and a drug that's suppose to help improve their health is just leading to more and more problems. But while the manufacturer, GlaxoSmithKline, may not have to lose profits by pulling the drug from shelves, they do have to answer to several angry families who are suing over the death of a loved one.

No comments: